Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-01-16 @ 3:21 AM
Study NCT ID:
NCT02923934
Status:
COMPLETED
Last Update Posted:
2024-07-24
First Post:
2016-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Sponsor:
Olivia Newton-John Cancer Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ONJ2016-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |